| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $0.8B | $0.6B | $0.6B | $0.0B | — |
| Cost of Revenue | $2.6B | $1.7B | $1.9B | $1.6B | $0.2B | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | $1.2B | $1.2B | $0.9B | $0.8B | $0.8B | — |
| SG&A Expense | $1.0B | $0.9B | $0.8B | $0.7B | $0.7B | — |
| Operating Income | $-3.5B | $-3.0B | $-3.1B | $-2.6B | $-1.5B | $-0.0B |
| Net Income | $-2.7B | $-2.7B | $-2.8B | $-1.3B | $-2.6B | $-0.0B |
| EPS (Basic) | $-11.81 | $-1.25 | $-1.36 | $-0.78 | $-6.41 | — |
| EPS (Diluted) | $-12.09 | $-1.25 | $-1.36 | $-1.51 | $-6.41 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $8.4B | $9.6B | $8.5B | $7.9B | $7.9B | $2.1B |
| Current Assets | $3.3B | $4.9B | $4.8B | $4.9B | $6.5B | $0.0B |
| Cash & Equivalents | $1.0B | $1.6B | $1.4B | $1.7B | $6.3B | $0.0B |
| Total Liabilities | $5.4B | $4.5B | $3.7B | $3.5B | $4.0B | $0.1B |
| Current Liabilities | $2.6B | $1.2B | $1.0B | $0.9B | $0.4B | — |
| Stockholders' Equity | $0.7B | $3.9B | $4.9B | $4.3B | $3.9B | $0.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $-2.9B | $-2.0B | $-2.5B | $-2.2B | $-1.1B | $-0.0B |
| Investing Cash Flow | $1.5B | $-1.3B | $-0.9B | $-3.7B | $-0.4B | $-2.1B |
| Capital Expenditures | $0.9B | $0.9B | $0.9B | $1.1B | — | — |
| Financing Cash Flow | $0.9B | $3.5B | $3.1B | $1.3B | $7.1B | $2.1B |